Overview Dividends

(SLAB) Silicon Laboratories - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8269191024

Wireless, Microcontrollers, Sensors, Mixed-Signal

SLAB EPS (Earnings per Share)

EPS Growth (3Y CAGR): -40.10%
EPS Trend (3Y Correlation): -43.0%

SLAB Revenue

Revenue Growth (3Y CAGR): -7.77%
Revenue Trend (3Y Correlation): -21.5%

Risk via 10d forecast
Volatility	45.6%
Value at Risk 5%th	70.1%

Reward
Sharpe Ratio	0.48
Alpha Jensen	-8.73

Character
Hurst Exponent	0.489
Beta	1.555

Drawdowns 3y
Max DD	55.35%
Mean DD	30.53%

Description: SLAB Silicon Laboratories November 06, 2025

Silicon Laboratories (NASDAQ: SLAB) is a fabless semiconductor firm that designs analog-intensive mixed-signal solutions, chiefly wireless microcontrollers and sensor products, for a broad spectrum of industrial and commercial IoT applications.

Its portfolio powers devices ranging from smart-home cameras, locks, HVAC controls, and lighting to industrial automation, electric-vehicle charging stations, renewable-energy inverters, and medical-grade monitoring equipment. The company reaches customers through a direct sales force complemented by independent reps and global distributors.

In FY 2023 SLAB reported revenue of roughly $1.2 billion, a year-over-year increase of about 9%, with a gross margin near 73% and R&D spending at 20% of sales-metrics that underscore its high-value-add design focus. The broader IoT market is projected to grow at a CAGR of 13% through 2030, while the U.S. CHIPS Act and easing semiconductor supply constraints are expected to benefit fabless players that can leverage domestic incentives.

For anyone looking to dig deeper into how SLAB’s growth dynamics compare with peers, a quick look at ValueRay’s detailed analyst dashboards can provide the quantitative context you need.

SLAB Stock Overview

Market Cap in USD	4,153m
Sub-Industry	Semiconductors
IPO / Inception	2000-03-23
Return 12m vs S&P 500	4.18%
Analyst Rating	3.73 of 5

SLAB Dividends

Currently no dividends paid

SLAB Growth Ratios

CAGR	-3.50%
CAGR/Max DD Calmar Ratio	-0.06
CAGR/Mean DD Pain Ratio	-0.11
Current Volume	185.1k
Average Volume	266.6k

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (-86.0m TTM) > 0 and > 6% of Revenue (6% = 44.6m TTM)

FCFTA 0.06 (>2.0%) and ΔFCFTA 7.25pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 68.29% (prev 98.19%; Δ -29.90pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.08 (>3.0%) and CFO 97.5m > Net Income -86.0m (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 4.49 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (32.8m) change vs 12m ago 1.63% (target <= -2.0% for YES)

Gross Margin 55.89% (prev 53.88%; Δ 2.00pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 59.37% (prev 40.42%; Δ 18.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -83.56 (EBITDA TTM -43.8m / Interest Expense TTM 1.02m) >= 6 (WARN >= 3)

Altman Z'' 10.05

(A) 0.40 = (Total Current Assets 652.6m - Total Current Liabilities 145.3m) / Total Assets 1.25b

(B) 0.75 = Retained Earnings (Balance) 939.5m / Total Assets 1.25b

(D) 5.15 = Book Value of Equity 939.7m / Total Liabilities 182.4m

Total Rating: 10.05 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 35.36

1. Piotroski 4.50pt = -0.50

2. FCF Yield 1.97% = 0.99

3. FCF Margin 9.91% = 2.48

4. Debt/Equity 0.01 = 2.50

5. Debt/Ebitda 7.80 = -2.50

6. ROIC - WACC (= -20.03)% = -12.50

7. RoE -8.04% = -1.34

8. Rev. Trend -21.47% = -1.61

9. EPS Trend -43.04% = -2.15

What is the price of SLAB shares?

As of November 13, 2025, the stock is trading at USD 126.95 with a total of 185,111 shares traded.
Over the past week, the price has changed by -1.98%, over one month by -1.63%, over three months by -3.00% and over the past year by +20.72%.

Is Silicon Laboratories a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Silicon Laboratories (NASDAQ:SLAB) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 35.36 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SLAB is around 110.64 USD . This means that SLAB is currently overvalued and has a potential downside of -12.85%.

Is SLAB a buy, sell or hold?

Silicon Laboratories has received a consensus analysts rating of 3.73. Therefor, it is recommend to hold SLAB.

Strong Buy: 3
Buy: 2
Hold: 6
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the SLAB price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	151.3	19.2%
Analysts Target Price	151.3	19.2%
ValueRay Target Price	126.9	-0%

SLAB Fundamental Data Overview November 11, 2025

Market Cap USD = 4.15b (4.15b USD * 1.0 USD.USD)
P/E Forward = 56.8182
P/S = 5.5913
P/B = 4.1296
P/EG = 3.0343
Beta = 1.555
Revenue TTM = 742.8m USD
EBIT TTM = -85.3m USD
EBITDA TTM = -43.8m USD
Long Term Debt = 15.5m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = unknown (none)
Debt = 15.5m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -341.4m USD (from netDebt column, last quarter)
Enterprise Value = 3.73b USD (4.15b + Debt 15.5m - CCE 439.0m)
Interest Coverage Ratio = -83.56 (Ebit TTM -85.3m / Interest Expense TTM 1.02m)
FCF Yield = 1.97% (FCF TTM 73.6m / Enterprise Value 3.73b)
FCF Margin = 9.91% (FCF TTM 73.6m / Revenue TTM 742.8m)
Net Margin = -11.58% (Net Income TTM -86.0m / Revenue TTM 742.8m)
Gross Margin = 55.89% ((Revenue TTM 742.8m - Cost of Revenue TTM 327.7m) / Revenue TTM)
Gross Margin QoQ = 57.78% (prev 56.06%)
Tobins Q-Ratio = 2.98 (Enterprise Value 3.73b / Total Assets 1.25b)
Interest Expense / Debt = 1.45% (Interest Expense 226.0k / Debt 15.5m)
Taxrate = -4.35% (negative due to tax credits) (414.0k / -9.52m)
NOPAT = -89.0m (EBIT -85.3m * (1 - -4.35%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 4.49 (Total Current Assets 652.6m / Total Current Liabilities 145.3m)
Debt / Equity = 0.01 (Debt 15.5m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = 7.80 (negative EBITDA) (Net Debt -341.4m / EBITDA -43.8m)
Debt / FCF = -4.64 (Net Debt -341.4m / FCF TTM 73.6m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -6.87% (Net Income -86.0m / Total Assets 1.25b)
RoE = -8.04% (Net Income TTM -86.0m / Total Stockholder Equity 1.07b)
RoCE = -7.86% (EBIT -85.3m / Capital Employed (Equity 1.07b + L.T.Debt 15.5m))
RoIC = -8.32% (negative operating profit) (NOPAT -89.0m / Invested Capital 1.07b)
WACC = 11.71% (E(4.15b)/V(4.17b) * Re(11.75%) + D(15.5m)/V(4.17b) * Rd(1.45%) * (1-Tc(-0.04)))
Discount Rate = 11.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.54%
[DCF Debug] Terminal Value 55.78% ; FCFE base≈73.6m ; Y1≈48.3m ; Y5≈22.1m
Fair Price DCF = 8.14 (DCF Value 267.5m / Shares Outstanding 32.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -43.04 | EPS CAGR: -40.10% | SUE: 0.13 | # QB: 0
Revenue Correlation: -21.47 | Revenue CAGR: -7.77% | SUE: 0.39 | # QB: 0

Additional Sources for SLAB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle